FIELD: biotechnologies.
SUBSTANCE: invention relates to the biotechnology. Methods include obtaining a sample from an animal; analysing the sample to determine the amount of micro-RNA (siRNA) associated with the chronic valve disease; comparing the amount of siRNA found in the sample with the corresponding amount of siRNA present in the sample obtained from one or more comparable control animals that do not suffer chronic disease of the valves; and diagnosing an animal with chronic valve disease if the amount of siRNA found in the animal's sample is differentially expressed in the control animal's sample.
EFFECT: there are presented methods for diagnosing chronic disease of valves in an animal.
14 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MARKERS OF TUMOR CELL RESPONSE TO ANTI-CANCER THERAPY | 2014 |
|
RU2664180C2 |
METHOD FOR DIAGNOSING HEPATIC PATHOLOGIES IN DOGS USING CFA-MIRNAS | 2020 |
|
RU2758950C1 |
MICRO-RNA-BIOMARKERS INDICATING ALZHEIMER'S DISEASE | 2012 |
|
RU2639509C2 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF ACUTE AND CHRONIC HEPATITIS IN DOGS BASED ON CFA-MRNA EXPRESSION IN BLOOD SERUM | 2021 |
|
RU2768154C1 |
REGULATION OF METABOLISM USING MIR-378 | 2011 |
|
RU2585491C2 |
METHOD OF SELECTING FOOD DIET, PROVIDING OBTAINING MILK, POSSESSING IMMUNOSTIMULATING ACTION | 2010 |
|
RU2545377C2 |
METHOD FOR PREDICTION OF RISK OF RECURRENT THYROID CANCER AFTER RADICAL SURGERY | 2024 |
|
RU2822578C1 |
METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
MIRNA DEFINITION PLASMA FOR DETECTION OF EARLY STAGES OF COLORECTAL CANCER | 2012 |
|
RU2611189C2 |
METHOD FOR PRODUCING INDUCED REPROGRAMMED DERIVATIVE NEURONAL STEM CELLS FROM NON-NEURONAL CELLS BY USING HMGA2 | 2014 |
|
RU2646099C2 |
Authors
Dates
2020-01-23—Published
2016-02-04—Filed